003850.KS Overview

Company Profile

Related stocks

185750.KS • South Korea

CHONGKUNDANG

65,900 KRW

647.98M USD 1Y -19.9%

195940.KQ • South Korea

HK inno.N

39,700 KRW

839.31M USD 1Y -13.3%

069620.KS • South Korea

DAEWOONG PHARM

108,500 KRW

931.65M USD 1Y -18.3%

3613.HK • Hong Kong SAR China

TONGRENTANGCM

5.57 HKD

594.18M USD 1Y -37.8%

006280.KS • South Korea

GC Biopharma Corp.

129,400 KRW

1.1B USD 1Y -2.2%

FDC.BO • India

FDC LTD.

330.1 INR

555.32M USD 1Y -27.9%

300485.SZ • China

SCIENCE SUN

8.57 CNY

617.67M USD 1Y -24%

4559.T • Japan

ZERIA PHARMACEUTICAL

1,925 JPY

536.21M USD 1Y -4.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

South Korea

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

36.4% p.a.

Max Drawdown (5Y)

-56.4%

Sharpe Ratio (5Y)

-0.34

Beta Factor

0.34

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -65.3% in the extended horizon.